HIGHLIGHTS
- who: TYPE et al. from the China Pharmaceutical University, China have published the paper: Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy, in the Journal: (JOURNAL)
- what: The authors focused on all glycometabolism-related genes in HCC and constructed a prognostic risk score for these genes. This study provides a new perspective for exploring the glycometabolism-immunity mechanism. Because of the correlation between drug sensitivity and poor prognosis, the authors focused on the relationship between risk score and drug sensitivity.
- how: Frontiers in Cell and Developmental Biology frontiersin.org . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.